Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease.
about
Therapeutic D2/3 receptor occupancies and response with low amisulpride blood concentrations in very late-onset schizophrenia-like psychosis (VLOSLP).Is antipsychotic sensitivity in Alzheimer's disease secondary to abnormal blood-brain barrier integrity?The D2 Dopamine Receptor Interferes With the Protective Effect of the A2A Adenosine Receptor on TDP-43 Mislocalization in Experimental Models of Motor Neuron Degeneration.Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial.Antipsychotic Drug Dispensations in Older Adults, Including Continuation After a Fall-Related Hospitalization: Identifying Adherence to Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria Using the Nova Scotia Seniors' P
P2860
Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Therapeutic window of dopamine ...... chosis in Alzheimer's disease.
@en
type
label
Therapeutic window of dopamine ...... chosis in Alzheimer's disease.
@en
prefLabel
Therapeutic window of dopamine ...... chosis in Alzheimer's disease.
@en
P2093
P2860
P50
P356
P1433
P1476
Therapeutic window of dopamine ...... ychosis in Alzheimer's disease
@en
P2093
Akshay Nair
Alan Smith
Emma McLachlan
Julie Bertrand
Paul Marsden
Robert Kessler
Stuart Brownings
Suki Greaves
Suzanne Reeves
P2860
P304
P356
10.1093/BRAIN/AWW359
P407
P577
2017-04-01T00:00:00Z